• Disclaimer
  • Privacy Policy
Media Coverage
  • Analyst Ratings
  • Market coverage
  • Business news
  • Wealth
  • Stock Markets
  • World Economy
  • About Us
    • About us
    • Contact
No Result
View All Result
  • Analyst Ratings
  • Market coverage
  • Business news
  • Wealth
  • Stock Markets
  • World Economy
  • About Us
    • About us
    • Contact
No Result
View All Result
Media Coverage
No Result
View All Result
Home Market coverage

Bollard Group LLC Cuts Stake in Colgate-Palmolive, Signals Change in Investment Strategy

Roberto Liccardo by Roberto Liccardo
September 4, 2023
in Market coverage
0
Ares Acquisition Misses Bloomberg’s Top Stocks List, TD Asset Management Reduces Holdings by 16.7%
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

On September 3, 2023, Bollard Group LLC revealed that it has decreased its ownership stake in Colgate-Palmolive (NYSE: CL) by 10.6% during the first quarter of this year. This update comes from the company’s latest disclosure with the U.S. Securities and Exchange Commission (SEC). The institutional investor now holds 64,938 shares of Colgate-Palmolive’s stock after selling 7,711 shares.

As of the most recent SEC filing, Bollard Group LLC’s holdings in Colgate-Palmolive were valued at $4,880,000. While this reduction may signify a change in Bollard Group LLC’s investment strategy regarding Colgate-Palmolive, further details surrounding their decision have not been disclosed.

In addition to their divestment news, Colgate-Palmolive recently announced that it has paid a quarterly dividend on August 15th. Shareholders who were recorded as such on July 21st received a dividend of $0.48 per share. The ex-dividend date for this payment was July 20th. This translates into an annualized dividend of $1.92 and represents a dividend yield of approximately 2.61%.

Currently, Colgate-Palmolive’s dividend payout ratio (DPR) stands at an elevated level of 106.67%. While a high DPR may indicate potential financial strain on the company to sustain its dividend payments in the long run, investors should consider other factors and metrics before drawing conclusions about the overall health and sustainability of Colgate-Palmolive’s operations.

It is essential to acknowledge that investing decisions cannot solely rely on one factor but require thorough analysis and consideration of various aspects such as financial performance, industry trends, and market conditions.

For more detailed information and insights into Colgate-Palmolive’s financial performance and market position, readers can refer to our latest report on the company, which provides a comprehensive overview and analysis. This report can be accessed through our platform to assist investors in making informed decisions based on reliable information.

As always, it is crucial for investors to conduct their research and seek advice from qualified professionals before making any financial or investment decisions. The information provided here should be used as a starting point for further investigation rather than a sole basis for decision-making.

Disclaimer: The content provided in this article is for informational purposes only and should not be construed as financial or investment advice.
[bs_slider_forecast ticker=”CL”]

Investor Interest and Analyst Sentiment Surrounding Colgate-Palmolive



Colgate-Palmolive, a well-known consumer goods company, has attracted the attention of several large investors who have either increased or reduced their stakes in the company. Tucker Asset Management LLC and Register Financial Advisors LLC recently acquired new positions in Colgate-Palmolive during the first quarter, with values of approximately $27,000 and $30,000 respectively. On the other hand, Capital Advisors Ltd. LLC expanded its holdings in shares of Colgate-Palmolive by 36.4% in the fourth quarter. The company now owns 704 shares worth $33,000 after purchasing an additional 188 shares.

It is worth mentioning that Kepos Capital LP also purchased a new position in shares of Colgate-Palmolive during the fourth quarter valued at $40,000. Additionally, US Asset Management LLC bought a new stake in Colgate-Palmolive worth $41,000 during the same period. These investments highlight the confidence and trust placed by prominent institutions on the company’s potential for growth and profitability.

Interestingly enough, hedge funds and other institutional investors own a significant portion of Colgate-Palmolive stock—78.36%, to be precise—suggesting a high level of interest from this investor segment.

Several analysts have provided their opinions regarding CL shares recently. Barclays increased their target price from $77.00 to $81.00 and issued an “equal weight” rating for Colgate-Palmolive’s stock on August 1st. Deutsche Bank Aktiengesellschaft also lifted their target price from $88.00 to $91.00 and gave the company a “buy” rating on July 31st.

In another note of optimism, StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating on August 25th—a sentiment further supported by Royal Bank of Canada as they reissued a “sector perform” rating and issued a target price of $83.00 for Colgate-Palmolive on July 31st.

Overall, four equities research analysts have given the stock a hold rating, while eight analysts believe it is a good buy. With input from several experts, Bloomberg.com reports that the stock currently has a consensus rating of “Moderate Buy” with an average price target of $85.33.

As of recent trading activity, CL traded down $0.03 on Friday to reach $73.44. Approximately 1,606,136 shares were exchanged, which is slightly below its average daily volume of 4,732,846 shares. Colgate-Palmolive’s 50-day simple moving average stands at $75.83, while its 200-day simple moving average is $75.85.

Colgate-Palmolive possesses an above-average current ratio of 1.17 and a quick ratio of 0.73—an indication of its robust liquidity position. Additionally, the company has exhibited financial stability with its debt-to-equity ratio standing at 28.43.

In terms of market cap, Colgate-Palmolive operates within the league of significant corporations with a marker cap valued at $60.71 billion. The company also carries a price-to-earnings ratio (P/E) of 40.82 and a P/E/G (price-earnings to growth) ratio of 3.13—a measure used to evaluate the value provided by the stock compared to its growth prospects.

On July 28th this year, Colgate-Palmolive released its quarterly earnings data for investors’ evaluation purposes—an event that drew attention from many market participants who eagerly awaited the results. The company reported earning $0.77 per share (EPS), surpassing market expectations by $0.02 per share ($0.75 EPS estimated). It is interesting to note that Colgate-Palmolive achieved a net margin of 8.02% and a return on equity of 386.76%. The company also generated revenues of $4.82 billion during the quarter, exceeding the consensus estimate of $4.70 billion—an increase of 7.5% in revenue compared to the same period last year.

Based on analysis and forecasts from research analysts, it is anticipated that Colgate-Palmolive will post an EPS of 3.17 for this year—an achievement that could uphold investor confidence in the company’s ability to deliver sustainable returns.

In conclusion, Colgate-Palmolive continues to attract interest from investors, both large institutions and individual analysts alike. With rising stakes from notable investment firms and positive sentiment from analysts, the consumer goods company’s stock may hold potential for growth in the market. As important financial figures are reported and future projections suggested, further insights can be gleaned to evaluate Colgate-Palmolive’s market position effectively.

Tags: CL
Previous Post

Recent Developments and Analyst Insights on ArcBest Co. (NASDAQ:ARCB) Stock

Next Post

Independent Advisor Alliance Reduces Holdings in The Walt Disney Company

Next Post
Stock market stock market (1)

Independent Advisor Alliance Reduces Holdings in The Walt Disney Company

Recent Posts

  • Emerging Trends in Biopharmaceutical Partnerships: How Companies are Forging Alliances for Medical Breakthroughs
  • Wedge Capital Management Increases Holdings in Arista Networks, Indicating Confidence in Its Growth Potential
  • Nordea Investment Management AB Decreases Position in Radware Ltd. as Company Reports Decline in Quarterly Revenue
  • Ocean Arete Ltd. Reduces Holdings in Trip.com Group Limited
  • Investing in Adolescent Health: How Vaccination Programs Shape Future Economic Landscapes
  • Nordea Investment Management AB Trims Position in Apollo Medical Holdings, Inc.: Market Dynamics and Investment Decisions in the Healthcare Services Sector

Categories

  • Analyst Ratings
  • Business
  • Business news
  • Market coverage
  • Pre-IPO & Startups
  • Stock Markets
  • Wealth
  • World Economy

About Us

Our team of experienced journalists and industry experts is committed to providing you with the latest and most accurate information on a wide range of topics, from finance and technology to politics and the economy.

We are proud to be part of the Best Stocks team and to offer our readers exceptional content that is informed by our combined expertise. We look forward to continuing to serve our readers and to playing a key role in the world of business analysis and reporting.

READ MORE

  • Media Contacts
  • Journalist Contacts
  • Contact
  • About us
  • Disclaimer
  • Privacy Policy

© 2023 Media Coverage

No Result
View All Result
  • Analyst Ratings
  • Market coverage
  • Business news
  • Wealth
  • Stock Markets
  • World Economy
  • About Us
    • About us
    • Contact

© 2023 Media Coverage